Your shopping cart is currently empty

Tau ProteinPhosphorylation-IN-1 is a tau protein phosphorylation inhibitor that effectively protects PC12 cells from Aβ25-35-induced cytotoxicity (EC50 = 1.93 μM) and is capable of crossing the blood-brain barrier. It reverses tau protein hyperphosphorylation both in vitro and in vivo, significantly suppresses the expression of immune-related cytotoxic factors, blocks the MAPK and NF-κB signaling pathways, and reduces the levels of RAGE and apoptosis factor Bax/Bcl-2. In Alzheimer's disease mouse models, Tau ProteinPhosphorylation-IN-1 alleviates neuronal damage and improves learning and memory capabilities. It is applicable for Alzheimer's disease research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Tau ProteinPhosphorylation-IN-1 is a tau protein phosphorylation inhibitor that effectively protects PC12 cells from Aβ25-35-induced cytotoxicity (EC50 = 1.93 μM) and is capable of crossing the blood-brain barrier. It reverses tau protein hyperphosphorylation both in vitro and in vivo, significantly suppresses the expression of immune-related cytotoxic factors, blocks the MAPK and NF-κB signaling pathways, and reduces the levels of RAGE and apoptosis factor Bax/Bcl-2. In Alzheimer's disease mouse models, Tau ProteinPhosphorylation-IN-1 alleviates neuronal damage and improves learning and memory capabilities. It is applicable for Alzheimer's disease research. |
| In vitro | Tau Protein Phosphorylation-IN-1 (compound B1) shows no toxicity to PC12 cells at a concentration of 30 μM for 24 hours and effectively counters Aβ 25-35-induced cytotoxicity at 10 μM. In PC12 cells exposed to Aβ 25-35, Tau Protein Phosphorylation-IN-1 (2.5-10 μM, 24 hours) exhibits neuroprotective effects through various mechanisms. It significantly reduces tau phosphorylation at Thr181, Thr205, and Ser396 sites, inhibits the phosphorylation of MAPKs (p38, ERK, JNK) and NF-κB, reverses Aβ-induced upregulation of iNOS and COX-2 expression, regulates apoptosis-related proteins Bax/Bcl-2 expression, and suppresses RAGE. |
| In vivo | Tau Protein Phosphorylation-IN-1, administered intraperitoneally at doses of 2.5, 5, and 10 mg/kg once daily for 28 days, effectively enhances cognitive function, reduces excessive tau protein phosphorylation, and suppresses neuroinflammation in a mouse model of Alzheimer's disease. |
| Molecular Weight | 628.9 |
| Formula | C39H56N4O3 |
| Cas No. | 3075165-36-2 |
| Smiles | C(OCCN1C(=NN=N1)C2=CC=CC=C2)(=O)[C@]34[C@](C=5[C@@](C)(CC3)[C@@]6(C)[C@](CC5)([C@]7(C)[C@@](CC6)(C(C)(C)[C@@H](O)CC7)[H])[H])(CC(C)(C)CC4)[H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.